Aydın Emrah, Nolan Heather, Peiró Jose Luis, Burns Patricia, Rymeski Beth, Lim Foong-Yen
Division of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 11025, Cincinnati, OH, 45229-3039, USA.
Pediatr Surg Int. 2020 Apr;36(4):485-491. doi: 10.1007/s00383-020-04634-y. Epub 2020 Mar 4.
Primary closure is often inadequate for large congenital diaphragmatic hernia (CDH) and necessitates repair by prosthetic patch or autologous muscle flap. Our aim was to evaluate outcomes of open patch versus flap repair, specifically diaphragmatic reherniation.
A retrospective review (IRB #2017-6361) was performed on all CDH patients repaired from 2005 to 2016 at a single academic children's hospital. Patients were excluded from final analysis if they had primary or minimally invasive repair, expired, or were lost to follow-up.
Of 171 patients, 151 (88.3%) survived to discharge, 9 expired after discharge and 11 were lost to follow up, leaving 131 (86.8%) long-term survivors. Median follow-up was 5 years. Open repair was performed in 119 (90.8%) of which 28 (23.5%) underwent primary repair, 34 (28.6%) patch repair, and 57 (47.9%) flap repair. Overall, 6/119 (5%) patients reherniated, 1/28 (3.6%) in the primary group, 3/34 (8.8%) in the patch group, and 2/57 (3.5%) in the flap group. Comparing prosthetic patch to muscle flap repair, there was no significant difference in the number of patients who recurred nor time to reherniation (3 vs. 2, p = 0.295; 5.5 ± 0.00 months vs. 53.75 ± 71.06 months, p = 0.288). One patient in the patch group recurred twice.
Both muscle flap and patch repair of large CDH are feasible and durable with a relatively low risk of recurrence.
对于大型先天性膈疝(CDH),一期缝合往往不够,需要使用人工补片或自体肌瓣进行修复。我们的目的是评估开放补片修复与肌瓣修复的效果,特别是膈肌再疝形成的情况。
对2005年至2016年在一家学术型儿童医院接受修复的所有CDH患者进行回顾性研究(IRB编号:2017 - 6361)。如果患者接受一期或微创修复、死亡或失访,则排除在最终分析之外。
171例患者中,151例(88.3%)存活至出院,9例出院后死亡,11例失访,131例(86.8%)为长期存活者。中位随访时间为5年。119例(90.8%)进行了开放修复,其中28例(23.5%)接受一期修复,34例(28.6%)接受补片修复,57例(47.9%)接受肌瓣修复。总体而言,119例患者中有6例(5%)发生再疝,一期修复组28例中有1例(3.6%),补片组34例中有3例(8.8%),肌瓣组57例中有2例(3.5%)。比较人工补片修复与肌瓣修复,复发患者数量和再疝形成时间均无显著差异(3例对2例,p = 0.295;5.5±0.00个月对53.75±71.06个月,p = 0.288)。补片组有1例患者复发两次。
大型CDH的肌瓣修复和补片修复都是可行且持久的,复发风险相对较低。